GLP-1
Clinical trials for GLP-1 explained in plain language.
Never miss a new study
Get alerted when new GLP-1 trials appear
Sign up with your email to follow new studies for GLP-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New supplement aims to boost natural hormones for weight loss and blood sugar control
Disease control CompletedThis study tested a dietary supplement called GLP-1 Booster in 69 overweight adults over 26 weeks. The goal was to see if it helps the body produce more GLP-1, a natural hormone that controls blood sugar, reduces appetite, and supports fat loss. Participants took either the suppl…
Matched conditions: GLP-1
Phase: NA • Sponsor: Lawry Han • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Supplements may prevent weight regain after GLP-1 drugs
Disease control CompletedThis study looked at whether taking a daily mix of dietary supplements (like polyphenols and prebiotics) for 12 weeks can help people who recently lost weight with GLP-1 drugs maintain their results. 70 adults who had lost at least 5% of their body weight and stopped their medica…
Matched conditions: GLP-1
Phase: NA • Sponsor: University of Alicante • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
Fiber bars tested for tummy troubles in Weight-Loss drug users
Symptom relief CompletedThis study looked at how different fiber snack bars affect stomach and bowel symptoms in adults who are already taking weight loss medications like Mounjaro, Ozempic, or Saxenda. Fifty participants tried three types of fiber bars and a control bar for one week each, reporting sym…
Matched conditions: GLP-1
Phase: NA • Sponsor: Midwest Center for Metabolic and Cardiovascular Research • Aim: Symptom relief
Last updated May 17, 2026 03:11 UTC
-
Weight loss shots linked to better mood and sleep in veterans
Symptom relief CompletedThis study looked at 90 veterans with obesity who took GLP-1 medicines (semaglutide or tirzepatide) for six months. Researchers found that participants reported significant improvements in depression symptoms, eating disorder behaviors, and overall quality of life, including less…
Matched conditions: GLP-1
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
Fitbit and coaching boost activity for weight loss drug users?
Knowledge-focused CompletedThis study tested whether a Fitbit activity tracker plus health coaching could help people with overweight or obesity who are already taking weight loss medications (GLP-1/GIP) become more active. Fifteen patients from a primary care clinic participated in a 12-week program where…
Matched conditions: GLP-1
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Knowledge-focused
Last updated May 04, 2026 16:24 UTC